Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;261(2):545-554.
doi: 10.1007/s00417-022-05811-6. Epub 2022 Aug 30.

Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome

Affiliations

Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome

Vijayalakshmi A Senthilkumar et al. Graefes Arch Clin Exp Ophthalmol. 2023 Feb.

Abstract

Purpose: To compare the surgical outcomes of the Aurolab aqueous drainage implant (AADI) and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to iridocorneal endothelial (ICE) syndrome.

Materials and methods: This retrospective comparative case series included 41 eyes of 41 patients with ICE syndrome and glaucoma who underwent either a trabeculectomy with MMC (n = 20) or AADI surgery (n = 21) with a minimum of 2 years follow-up. Outcome measures included intraocular pressure (IOP), the use of glaucoma medications, visual acuity, additional surgical interventions, and surgical complications. Surgical failure was defined as IOP > 21 mmHg or reduced < 20% from baseline, IOP ≤ 5 mmHg, reoperation for glaucoma or a complication, or loss of light perception vision.

Results: The cumulative probability of failure at 2 years was 50% in the trabeculectomy group (95%CI = 31-83%) and 24% in the AADI group (95%CI = 11-48%) (p = 0.09). The IOP was consistently lower in the AADI group compared with the trabeculectomy group at 6 months and thereafter. Surgical complications occurred in 13 eyes (65%) in the trabeculectomy group and 12 eyes (57%) in the AADI group (p = 0.71). Reoperations for glaucoma or complications were performed in 12 eyes (60%) in the trabeculectomy group and 5 patients (24%) in the tube group (p = 0.06). Cox proportional hazards showed that AADI had a 53% lower risk of failure at 2 years (p = 0.18; HR = 0.47; 95%CI = 0.16-1.40).

Conclusion: AADI surgery achieved lower mean IOPs than trabeculectomy with MMC in managing glaucoma secondary to ICE syndrome. A trend toward lower rates of surgical failure and reoperations for glaucoma and complications was observed following AADI placement compared with trabeculectomy with MMC in eyes with ICE syndrome.

Keywords: Aurolab aqueous drainage implant; Glaucoma drainage devices; Iridocorneal endothelial syndrome; Trabeculectomy with mitomycin.

PubMed Disclaimer

References

    1. Shields MB (1979) Progressive essential iris atrophy, Chandler’s syndrome, and the iris nevus (Cogan-Reese) syndrome: a spectrum of disease. Surv Ophthalmol 24:3–20. https://doi.org/10.1016/0039-6257(79)90143-7 - DOI
    1. Campbell DG, Shields MB, Smith TR (1978) The corneal endothelium and the spectrum of essential iris atrophy. Am J Ophthalmol 86:317–324. https://doi.org/10.1016/0002-9394(78)90232-5 - DOI
    1. Hirst LW, Quigley HA, Stark WJ, Shields MB (1980) Specular microscopy of iridocorneal endothelia syndrome. Am J Ophthalmol 89:11–21. https://doi.org/10.1016/0002-9394(80)90223-8 - DOI
    1. Sacchetti M, Mantelli F, Marenco M, et al (2015) Diagnosis and management of iridocorneal endothelial syndrome. Biomed Res Int 763093. https://doi.org/10.1155/2015/763093
    1. Silva L, Najafi A, Suwan Y, Teekhasaenee C, Ritch R (2018) The iridocorneal endothelial syndrome. Surv Ophthalmol 63:665–676 - DOI

MeSH terms

LinkOut - more resources